Hrt Financial LP Centogene N.V. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.36 - $0.71 $3,656 - $7,210	10,156 New	10,156 $3,000
Q4 2021 Feb 14, 2022	SELL	$4.56 - $10.56 $81,213 - $188,073	-17,810 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.9 - $11.72 $57,459 - $68,022	-5,804 Reduced 24.58%	17,810 $196,000
Q2 2021 Aug 16, 2021	BUY	$9.02 - $12.93 $212,998 - $305,329	23,614 New	23,614 $246,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.